Abstract: Provided herein are compositions, uses thereof, and methods for treating Autism or Autism Spectrum Disorder (ASD) in a subject in need thereof, wherein the compositions comprise a whey protein isolate and/or whey protein concentrate.
Abstract: Methods for increasing reelin (RELN) levels in the brain of a subject in need thereof, as well as compositions for use in such methods, are provided. In addition, methods and compositions are described herein which may be used in the treatment of neuropsychiatric or neurodegenerative disorders, such as schizophrenia and Alzheimer's disease (AD). Compositions described herein may comprise whey protein isolate and/or whey protein concentrate, a source of the glutathione precursor cysteine. The provided methods and compositions are not limited to increasing RELN levels, and may be used to correct a number of other neurological disregulations or abnormalities occurring in a subject in need thereof.
Type:
Application
Filed:
June 9, 2022
Publication date:
February 2, 2023
Applicant:
Immunotec Inc.
Inventors:
Hyman Morris SCHIPPER, Marisa Emily CRESSATTI, Wei SONG, Carmela GALINDEZ, Ayda TAVITIAN, Adrienne LIBERMAN, Daniel A. LINSEMAN
Abstract: Provided herein are methods, compositions, and uses thereof for preventing traumatic brain injury (TBI) in a subject, wherein a composition comprising whey protein isolate and/or whey protein concentrate may be administered to a subject pre-injury, thereby increasing resilience of the subject to TBI.
Type:
Application
Filed:
August 16, 2021
Publication date:
December 9, 2021
Applicant:
Immunotec Inc.
Inventors:
Elizabeth E. IGNOWSKI, Daniel A. LINSEMAN
Abstract: Provided herein are compositions, uses thereof, and methods for treating Autism or Autism Spectrum Disorder (ASD) in a subject in need thereof, wherein the compositions comprise a whey protein isolate and/or whey protein concentrate.
Abstract: Provided herein are methods, compositions, and uses thereof for preventing traumatic brain injury (TBI) in a subject, wherein a composition comprising whey protein isolate and/or whey protein concentrate may be administered to a subject pre-injury, thereby increasing resilience of the subject to TBI.
Type:
Application
Filed:
June 14, 2018
Publication date:
July 2, 2020
Applicant:
Immunotec Inc.
Inventors:
Elizabeth E. IGNOWSKI, Daniel A. LINSEMAN
Abstract: Methods for increasing reelin (RELN) levels in the brain of a subject in need thereof, as well as compositions for use in such methods, are provided. In addition, methods and compositions are described herein which may be used in the treatment of neuropsychiatric or neurodegenerative disorders, such as schizophrenia and Alzheimer's disease (AD). Compositions described herein may comprise whey protein isolate and/or whey protein concentrate, a source of the glutathione precursor cysteine. The provided methods and compositions are not limited to increasing RELN levels, and may be used to correct a number of other neurological disregulations or abnormalities occurring in a subject in need thereof.
Type:
Application
Filed:
September 19, 2017
Publication date:
August 29, 2019
Applicant:
Immunotec Inc.
Inventors:
Hyman Morris SCHIPPER, Marisa Emily CRESSATTI, Wei SONG, Carmela GALINDEZ, Ayda TAVITIAN, Adrienne LIBERMAN, Daniel A. LINSEMAN
Abstract: A method of treating allergies whereby hyposensitization to allergens to which the patient has been found to be sensitive by skin testing and history is induced by sequentially scheduled oral administration of titrated amounts of allergenic extracts in a liquid vehicle comprising defined proportions of a selected hexose monosaccharide and ethyl alcohol in water.